CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment
- Authors
- Kim, Ji-Young; Lee, Hwa-Yong; Park, Kwan-Kyu; Choi, Yang-Kyu; Nam, Jeong-Seok; Hong, In-Sun
- Issue Date
- 12-Apr-2016
- Publisher
- IMPACT JOURNALS LLC
- Keywords
- CWP232228; cancer stem cells; Wnt/beta-catenin signaling; CD133; ALDH
- Citation
- ONCOTARGET, v.7, no.15, pp.20395 - 20409
- Journal Title
- ONCOTARGET
- Volume
- 7
- Number
- 15
- Start Page
- 20395
- End Page
- 20409
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8382
- DOI
- 10.18632/oncotarget.7954
- ISSN
- 1949-2553
- Abstract
- Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not all liver CSCs contribute to tumor initiation, metastasis, and relapse. In the present study, we showed that liver CSCs with elevated Wnt/beta-catenin signaling possess much greater self-renewal and clonogenic potential. We further documented that the increased clonogenic potential of liver CSCs is highly associated with changes in Wnt/beta-catenin signaling and that Wnt/beta-catenin signaling activity is positively correlated with CD133 expression and aldehyde dehydrogenase (ALDH) enzymatic activity. Notably, the small molecule inhibitor CWP232228, which antagonizes the binding of beta-catenin to TCF in the nucleus, inhibits Wnt/beta-catenin signaling and depletes CD133(+)/ALDH(+) liver CSCs, thus ultimately diminishing the self-renewal capacity of CSCs and decreasing tumorigenicity in vitro and in vivo. Taken together, our findings suggest that CWP232228 acts as a candidate therapeutic agent for liver cancer by preferentially targeting liver CSCs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8382)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.